Plasma Fractionation Market Size, Share, and Outlook, H2-2025 Report- By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Others), By Application (Neurology, Immunology, Hematology, Pulmonology, Others), By End-User
Description
Plasma Fractionation Market Outlook
The global Plasma Fractionation Market Size is valued at $38.5 Billion in 2025 and is forecast to reach $65.6 Billion in 2032 at a CAGR of 7.9%.
The Plasma Fractionation Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Plasma Fractionation Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Others), By Application (Neurology, Immunology, Hematology, Pulmonology, Others), By End-User (Hospitals and Clinics, Clinical Research Laboratories, Academic institutes), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Plasma Fractionation Market Insights, 2025
The plasma fractionation market is essential for producing life-saving therapies derived from human plasma, including immunoglobulins, clotting factors, and albumin. These biologics are vital for treating immune deficiencies, hemophilia, and other rare diseases. Advances in fractionation techniques, such as chromatography and nanofiltration, have improved product yield, purity, and viral safety. Rising demand for plasma-derived therapies, particularly in emerging markets, is driving investment in plasma collection and processing infrastructure. Stringent quality and regulatory requirements necessitate robust testing and manufacturing processes, often leading to consolidation among major players with advanced capabilities. Global plasma supply remains a critical challenge, with donor recruitment and retention being ongoing priorities for industry stakeholders. Partnerships between plasma collection centers, biopharmaceutical companies, and healthcare providers are strengthening supply chains. The increasing prevalence of chronic and rare disorders is prompting governments to support domestic plasma collection programs. Continuous R&D efforts are exploring novel fractionation methods to improve efficiency and reduce costs. This market remains indispensable to the global biopharmaceutical landscape.
Five Trends Shaping the Global Plasma Fractionation Market in 2025 and Beyond
The global Plasma Fractionation Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Plasma Fractionation Industry?
The Plasma Fractionation Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Plasma Fractionation Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Plasma Fractionation Market Segment Insights
The Plasma Fractionation Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Others), By Application (Neurology, Immunology, Hematology, Pulmonology, Others), By End-User (Hospitals and Clinics, Clinical Research Laboratories, Academic institutes). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Plasma Fractionation Industry Value Chain
The chapter identifies potential companies and their operations across the global Plasma Fractionation Industry ecosystem. It assists decision-makers in evaluating global Plasma Fractionation Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Plasma Fractionation Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Plasma Fractionation Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Plasma Fractionation Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Plasma Fractionation Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Plasma Fractionation Market.
Europe Plasma Fractionation Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Plasma Fractionation Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Plasma Fractionation Industry competitiveness. The report analyses the key Plasma Fractionation Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Plasma Fractionation Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Plasma Fractionation Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Plasma Fractionation Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Plasma Fractionation Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Plasma Fractionation Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Plasma Fractionation Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes ADMA Biologics Inc, Bharat Serums and Vaccines Ltd, Centurion Pharma, China Biologic Products Holdings Inc, CSL Ltd, Emergent BioSolutions Inc, Fusion Healthcare, GC Pharma, Grifols S.A., Hemarus Therapeutics Ltd, Hualan Biological Engineering Inc, Intas Pharmaceuticals Ltd, Japan Blood Products Organization, Kamada Ltd, Kedrion S.p.A., LFB SA, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd, Prothya Biosolutions Pvt. Ltd, Sanquin Blood Supply Foundation, Shanghai RAAS Blood Products Co. Ltd, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd, SK Plasma Co. Ltd, Takeda Pharmaceutical Company Ltd, Virchow Biotech Private Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Plasma Fractionation Market Scope
Leading Segments
By Product
ImmunoglobulinsIntravenous Immunoglobulins Subcutaneous Immunoglobulins Others
Coagulation Factor ConcentratesFactor VIII Factor IX Von Willebrand Factor Others
Albumin
Protease Inhibitors
Others
By Application
Neurology
Immunology
Hematology
Pulmonology
Others
By End-User
Hospitals and Clinics
Clinical Research Laboratories
Academic institutes
Leading Companies
ADMA Biologics Inc
Bharat Serums and Vaccines Ltd
Centurion Pharma
China Biologic Products Holdings Inc
CSL Ltd
Emergent BioSolutions Inc
Fusion Healthcare
GC Pharma
Grifols S.A.
Hemarus Therapeutics Ltd
Hualan Biological Engineering Inc
Intas Pharmaceuticals Ltd
Japan Blood Products Organization
Kamada Ltd
Kedrion S.p.A.
LFB SA
Octapharma AG
PlasmaGen BioSciences Pvt. Ltd
Prothya Biosolutions Pvt. Ltd
Sanquin Blood Supply Foundation
Shanghai RAAS Blood Products Co. Ltd
Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd
SK Plasma Co. Ltd
Takeda Pharmaceutical Company Ltd
Virchow Biotech Private Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Plasma Fractionation Market Size is valued at $38.5 Billion in 2025 and is forecast to reach $65.6 Billion in 2032 at a CAGR of 7.9%.
The Plasma Fractionation Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Plasma Fractionation Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Others), By Application (Neurology, Immunology, Hematology, Pulmonology, Others), By End-User (Hospitals and Clinics, Clinical Research Laboratories, Academic institutes), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Plasma Fractionation Market Insights, 2025
The plasma fractionation market is essential for producing life-saving therapies derived from human plasma, including immunoglobulins, clotting factors, and albumin. These biologics are vital for treating immune deficiencies, hemophilia, and other rare diseases. Advances in fractionation techniques, such as chromatography and nanofiltration, have improved product yield, purity, and viral safety. Rising demand for plasma-derived therapies, particularly in emerging markets, is driving investment in plasma collection and processing infrastructure. Stringent quality and regulatory requirements necessitate robust testing and manufacturing processes, often leading to consolidation among major players with advanced capabilities. Global plasma supply remains a critical challenge, with donor recruitment and retention being ongoing priorities for industry stakeholders. Partnerships between plasma collection centers, biopharmaceutical companies, and healthcare providers are strengthening supply chains. The increasing prevalence of chronic and rare disorders is prompting governments to support domestic plasma collection programs. Continuous R&D efforts are exploring novel fractionation methods to improve efficiency and reduce costs. This market remains indispensable to the global biopharmaceutical landscape.
Five Trends Shaping the Global Plasma Fractionation Market in 2025 and Beyond
The global Plasma Fractionation Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Plasma Fractionation Industry?
The Plasma Fractionation Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Plasma Fractionation Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Plasma Fractionation Market Segment Insights
The Plasma Fractionation Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Others), By Application (Neurology, Immunology, Hematology, Pulmonology, Others), By End-User (Hospitals and Clinics, Clinical Research Laboratories, Academic institutes). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Plasma Fractionation Industry Value Chain
The chapter identifies potential companies and their operations across the global Plasma Fractionation Industry ecosystem. It assists decision-makers in evaluating global Plasma Fractionation Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Plasma Fractionation Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Plasma Fractionation Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Plasma Fractionation Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Plasma Fractionation Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Plasma Fractionation Market.
Europe Plasma Fractionation Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Plasma Fractionation Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Plasma Fractionation Industry competitiveness. The report analyses the key Plasma Fractionation Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Plasma Fractionation Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Plasma Fractionation Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Plasma Fractionation Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Plasma Fractionation Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Plasma Fractionation Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Plasma Fractionation Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes ADMA Biologics Inc, Bharat Serums and Vaccines Ltd, Centurion Pharma, China Biologic Products Holdings Inc, CSL Ltd, Emergent BioSolutions Inc, Fusion Healthcare, GC Pharma, Grifols S.A., Hemarus Therapeutics Ltd, Hualan Biological Engineering Inc, Intas Pharmaceuticals Ltd, Japan Blood Products Organization, Kamada Ltd, Kedrion S.p.A., LFB SA, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd, Prothya Biosolutions Pvt. Ltd, Sanquin Blood Supply Foundation, Shanghai RAAS Blood Products Co. Ltd, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd, SK Plasma Co. Ltd, Takeda Pharmaceutical Company Ltd, Virchow Biotech Private Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Plasma Fractionation Market Scope
Leading Segments
By Product
Immunoglobulins
Coagulation Factor Concentrates
Albumin
Protease Inhibitors
Others
By Application
Neurology
Immunology
Hematology
Pulmonology
Others
By End-User
Hospitals and Clinics
Clinical Research Laboratories
Academic institutes
Leading Companies
ADMA Biologics Inc
Bharat Serums and Vaccines Ltd
Centurion Pharma
China Biologic Products Holdings Inc
CSL Ltd
Emergent BioSolutions Inc
Fusion Healthcare
GC Pharma
Grifols S.A.
Hemarus Therapeutics Ltd
Hualan Biological Engineering Inc
Intas Pharmaceuticals Ltd
Japan Blood Products Organization
Kamada Ltd
Kedrion S.p.A.
LFB SA
Octapharma AG
PlasmaGen BioSciences Pvt. Ltd
Prothya Biosolutions Pvt. Ltd
Sanquin Blood Supply Foundation
Shanghai RAAS Blood Products Co. Ltd
Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd
SK Plasma Co. Ltd
Takeda Pharmaceutical Company Ltd
Virchow Biotech Private Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
189 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Plasma Fractionation Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Plasma Fractionation Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Plasma Fractionation Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Plasma Fractionation Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Plasma Fractionation Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Product
- Immunoglobulins
- -Intravenous Immunoglobulins
- -Subcutaneous Immunoglobulins
- -Others
- Coagulation Factor Concentrates
- -Factor VIII
- -Factor IX
- -Von Willebrand Factor
- -Others
- Albumin
- Protease Inhibitors
- Others
- By Application
- Neurology
- Immunology
- Hematology
- Pulmonology
- Others
- By End-User
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic institutes
- 6. Global Plasma Fractionation Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Plasma Fractionation Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Plasma Fractionation Market Trends and Growth Opportunities
- 6.2.1 North America Plasma Fractionation Market Outlook by Type
- 6.2.2 North America Plasma Fractionation Market Outlook by Application
- 6.3 North America Plasma Fractionation Market Outlook by Country
- 6.3.1 The US Plasma Fractionation Market Outlook, 2021- 2032
- 6.3.2 Canada Plasma Fractionation Market Outlook, 2021- 2032
- 6.3.3 Mexico Plasma Fractionation Market Outlook, 2021- 2032
- 7. Europe Plasma Fractionation Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Plasma Fractionation Market Trends and Growth Opportunities
- 7.2.1 Europe Plasma Fractionation Market Outlook by Type
- 7.2.2 Europe Plasma Fractionation Market Outlook by Application
- 7.3 Europe Plasma Fractionation Market Outlook by Country
- 7.3.2 Germany Plasma Fractionation Market Outlook, 2021- 2032
- 7.3.3 France Plasma Fractionation Market Outlook, 2021- 2032
- 7.3.4 The UK Plasma Fractionation Market Outlook, 2021- 2032
- 7.3.5 Spain Plasma Fractionation Market Outlook, 2021- 2032
- 7.3.6 Italy Plasma Fractionation Market Outlook, 2021- 2032
- 7.3.7 Russia Plasma Fractionation Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Plasma Fractionation Market Outlook, 2021- 2032
- 8. Asia Pacific Plasma Fractionation Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Plasma Fractionation Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Plasma Fractionation Market Outlook by Type
- 8.2.2 Asia Pacific Plasma Fractionation Market Outlook by Application
- 8.3 Asia Pacific Plasma Fractionation Market Outlook by Country
- 8.3.1 China Plasma Fractionation Market Outlook, 2021- 2032
- 8.3.2 India Plasma Fractionation Market Outlook, 2021- 2032
- 8.3.3 Japan Plasma Fractionation Market Outlook, 2021- 2032
- 8.3.4 South Korea Plasma Fractionation Market Outlook, 2021- 2032
- 8.3.5 Australia Plasma Fractionation Market Outlook, 2021- 2032
- 8.3.6 South East Asia Plasma Fractionation Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Plasma Fractionation Market Outlook, 2021- 2032
- 9. South America Plasma Fractionation Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Plasma Fractionation Market Trends and Growth Opportunities
- 9.2.1 South America Plasma Fractionation Market Outlook by Type
- 9.2.2 South America Plasma Fractionation Market Outlook by Application
- 9.3 South America Plasma Fractionation Market Outlook by Country
- 9.3.1 Brazil Plasma Fractionation Market Outlook, 2021- 2032
- 9.3.2 Argentina Plasma Fractionation Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Plasma Fractionation Market Outlook, 2021- 2032
- 10. Middle East and Africa Plasma Fractionation Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Plasma Fractionation Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Plasma Fractionation Market Outlook by Type
- 10.2.2 Middle East and Africa Plasma Fractionation Market Outlook by Application
- 10.3 Middle East and Africa Plasma Fractionation Market Outlook by Country
- 10.3.1 Saudi Arabia Plasma Fractionation Market Outlook, 2021- 2032
- 10.3.2 The UAE Plasma Fractionation Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Plasma Fractionation Market Outlook, 2021- 2032
- 10.3.4 South Africa Plasma Fractionation Market Outlook, 2021- 2032
- 10.3.5 Egypt Plasma Fractionation Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Plasma Fractionation Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- ADMA Biologics Inc
- Bharat Serums and Vaccines Ltd
- Centurion Pharma
- China Biologic Products Holdings Inc
- CSL Ltd
- Emergent BioSolutions Inc
- Fusion Healthcare
- GC Pharma
- Grifols S.A.
- Hemarus Therapeutics Ltd
- Hualan Biological Engineering Inc
- Intas Pharmaceuticals Ltd
- Japan Blood Products Organization
- Kamada Ltd
- Kedrion S.p.A.
- LFB SA
- Octapharma AG
- PlasmaGen BioSciences Pvt. Ltd
- Prothya Biosolutions Pvt. Ltd
- Sanquin Blood Supply Foundation
- Shanghai RAAS Blood Products Co. Ltd
- Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd
- SK Plasma Co. Ltd
- Takeda Pharmaceutical Company Ltd
- Virchow Biotech Private Ltd
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
